NCT04268394View on ClinicalTrials.gov

A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 13, 2020

Primary Completion Date

June 2, 2021

Study Completion Date

June 2, 2021

Conditions
Healthy Volunteer
Interventions
DRUG

CC-99677

CC-99677

DRUG

Methotrexate

Methotrexate

DRUG

Sulfasalazine

Sulfasalazine

DRUG

Itraconazole

Itraconazole

DRUG

Rifampin

Rifampin

DRUG

Midazolam

Midazolam

DRUG

Digoxin

Digoxin

DRUG

Metformin

Metformin

DRUG

Rosuvastatin

Rosuvastatin

Trial Locations (1)

SW17 ORE

Richmond Pharmacology Limited, London

Sponsors

Lead Sponsor

Celgene
All Listed Sponsors
lead

Celgene

INDUSTRY